BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10364793)

  • 1. [Tissue plasminogen activator as a prognostic factor in myocardial infarct patients].
    Fernández Abellán P; Marín Ortuño F; Marco Vera P; Luján Martínez J
    Rev Clin Esp; 1999 Apr; 199(4):215-7. PubMed ID: 10364793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.
    Schved JF; Gris JC; Arnaud A; Martinez P; Sanchez N; Wautier JL; Sarlat C
    J Lab Clin Med; 1992 Sep; 120(3):411-9. PubMed ID: 1517688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction.
    Andreotti F; Hackett DR; Haider AW; Roncaglioni MC; Davies GJ; Beacham JL; Kluft C; Maseri A
    Thromb Haemost; 1992 Dec; 68(6):678-82. PubMed ID: 1287882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
    Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
    Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
    Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
    Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction.
    Van Dreden P; Rousseau A; Savoure A; Lenormand B; Fontaine S; Vasse M
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):635-41. PubMed ID: 19809306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
    Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
    Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality.
    Collet JP; Montalescot G; Vicaut E; Ankri A; Walylo F; Lesty C; Choussat R; Beygui F; Borentain M; Vignolles N; Thomas D
    Circulation; 2003 Jul; 108(4):391-4. PubMed ID: 12860898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes.
    Passoni F; Morelli B; Seveso G; Lazzati L; Beria G; Del Rosso G; D'Urbano M; Cafiero F; Mariani G; De Servi S
    Ital Heart J; 2002 Jan; 3(1):28-33. PubMed ID: 11899586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of different treatments on plasma t-PA and PAI activity in AMI].
    Zhu G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Oct; 15(5):374-9. PubMed ID: 8168223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
    Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
    Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction.
    Jansson JH; Nilsson TK; Johnson O
    Heart; 1998 Oct; 80(4):334-7. PubMed ID: 9875107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
    Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
    Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in tissue plasminogen activator and plasminogen activator inhibitor during administration of nitroglycerine into internal thoracic artery in dogs with acute myocardial ischemia].
    Wu X; Wang CF; Sheng J; Zhu J
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):527-9. PubMed ID: 15355613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
    Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
    Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The kinetics of plasma coagulation fibrinolysis levels in acute myocardial infarction before and after treatment with intravenous urokinase].
    Bai XJ; Chen CX; He YL
    Zhonghua Nei Ke Za Zhi; 1991 Apr; 30(4):205-7, 253. PubMed ID: 1908371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.